Methods of treating coronavirus infections
AssigneeEagle Pharmaceuticals, Inc.
InventorAdrian HEPNER
Life of this patent
Estimating the term…
Abstract
The disclosure is directed to methods of using dantrolene or a dantrolene prodrug, or a pharmaceutically acceptable salt thereof, to treat coronavirus infections.
Claims20
A method of treating a coronavirus infection in a subject comprising administering to the subject dantrolene or a pharmaceutically acceptable salt thereof or by administering a dantrolene prodrug or a pharmaceutically acceptable salt thereof.
A method for inhibiting replication of a coronavirus in a subject comprising administering to the subject dantrolene, or a pharmaceutically acceptable salt thereof or by administering a dantrolene prodrug or a pharmaceutically acceptable salt thereof.
A method for inhibiting replication of a coronavirus in a host cell, for inhibiting entry of a coronavirus into a host cell, for inhibiting a coronavirus virion maturation in a host cell, or for inhibiting release of a coronavirus from a host cell comprising administering to the host cell dantrolene, or a pharmaceutically acceptable salt thereof or by administering a dantrolene prodrug or a pharmaceutically acceptable salt thereof.
A method for reducing the infectivity of a coronavirus by administering to a host cell dantrolene, or a pharmaceutically acceptable salt thereof or by administering a dantrolene prodrug or a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.